FTC Tells Congress To Scrap Pay-For-Delay

Law360, New York (January 13, 2010, 5:47 PM EST) -- The Federal Trade Commission has called for Congress to ban pay-for-delay in its health care reform package, saying that the settlements between generic drugmakers and their brand-name rivals will cost consumers and the government $35 billion over the next 10 years.

Drugmakers struck pay-for-delay deals 19 times in 2009, up from zero as recently as 2004, the FTC said in a report released Wednesday. In pay-for-delay settlements, generic drugmakers sued by their brand-name competition for patent infringement agree to take money and delay the introduction of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.